Compare Pfizer with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs STERLING BIOTECH - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER STERLING BIOTECH PFIZER/
STERLING BIOTECH
 
P/E (TTM) x 35.9 -0.4 - View Chart
P/BV x 6.1 0.0 42,585.8% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 PFIZER   STERLING BIOTECH
EQUITY SHARE DATA
    PFIZER
Mar-19
STERLING BIOTECH
Dec-13
PFIZER/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs3,84011 36,571.4%   
Low Rs2,0803 61,176.5%   
Sales per share (Unadj.) Rs455.026.8 1,697.2%  
Earnings per share (Unadj.) Rs93.8-15.0 -627.0%  
Cash flow per share (Unadj.) Rs109.4-5.5 -2,002.4%  
Dividends per share (Unadj.) Rs22.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs658.254.9 1,199.3%  
Shares outstanding (eoy) m45.75267.87 17.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.50.3 2,509.4%   
Avg P/E ratio x31.6-0.5 -6,792.5%  
P/CF ratio (eoy) x27.1-1.3 -2,126.9%  
Price / Book Value ratio x4.50.1 3,551.1%  
Dividend payout %24.00-   
Avg Mkt Cap Rs m135,4201,862 7,274.0%   
No. of employees `0002.61.4 194.3%   
Total wages/salary Rs m3,238547 592.2%   
Avg. sales/employee Rs Th7,911.45,303.3 149.2%   
Avg. wages/employee Rs Th1,230.9403.8 304.8%   
Avg. net profit/employee Rs Th1,630.7-2,959.0 -55.1%   
INCOME DATA
Net Sales Rs m20,8157,181 289.9%  
Other income Rs m1,67443 3,929.3%   
Total revenues Rs m22,4897,223 311.3%   
Gross profit Rs m5,712947 603.2%  
Depreciation Rs m7142,543 28.1%   
Interest Rs m734,377 1.7%   
Profit before tax Rs m6,599-5,931 -111.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,309-1,924 -120.0%   
Profit after tax Rs m4,291-4,007 -107.1%  
Gross profit margin %27.413.2 208.1%  
Effective tax rate %35.032.4 107.8%   
Net profit margin %20.6-55.8 -36.9%  
BALANCE SHEET DATA
Current assets Rs m27,16714,335 189.5%   
Current liabilities Rs m8,91749,809 17.9%   
Net working cap to sales %87.7-494.0 -17.7%  
Current ratio x3.00.3 1,058.6%  
Inventory Days Days68403 16.8%  
Debtors Days Days30171 17.6%  
Net fixed assets Rs m8,86255,432 16.0%   
Share capital Rs m458268 170.8%   
"Free" reserves Rs m29,65613,935 212.8%   
Net worth Rs m30,11314,701 204.8%   
Long term debt Rs m259,478 0.3%   
Total assets Rs m39,40073,988 53.3%  
Interest coverage x91.5-0.4 -25,783.9%   
Debt to equity ratio x00.6 0.1%  
Sales to assets ratio x0.50.1 544.3%   
Return on assets %11.10.5 2,211.0%  
Return on equity %14.2-27.3 -52.3%  
Return on capital %22.1-6.4 -344.5%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m4281,860 23.0%   
Fx outflow Rs m78625 3,159.5%   
Net fx Rs m-3581,835 -19.5%   
CASH FLOW
From Operations Rs m9781,719 56.9%  
From Investments Rs m351-3,148 -11.2%  
From Financial Activity Rs m-1,0991,426 -77.0%  
Net Cashflow Rs m231-3 -6,788.2%  

Share Holding

Indian Promoters % 0.0 33.9 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.0 -  
FIIs % 4.9 9.9 49.5%  
ADR/GDR % 0.0 16.9 -  
Free float % 23.7 39.3 60.3%  
Shareholders   85,207 21,482 396.6%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  STRIDES PHARMA SCIENCE  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Nov 11, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS